Integrated Symposia at ECCMID 2019

Rapid Diagnostics Direct from Whole Blood: A Solution for Fast and Appropriate Antimicrobial Therapy

15 April 2019 Ι 16:00-18:00 Ι Hall D

Experts will discuss integrating the FDA-cleared, CE-marked T2Bacteria® and T2Candida® Panels in clinical practice and the impact on patient management. Be among the first to hear data on the T2Resistance™ Panel, a diagnostic panel that can detect 13 resistance genes from both gram-negative and gram-positive pathogens from a single patient blood sample, without requiring blood culture.


  • Prof. Emmanuel Roilides, MD Aristotle University of Thessaloniki, Thessaloniki, Greece
  • Prof. Karsten Becker, MD University Hospital Münster, Institute of Medical Microbiology, Münster, Germany


  • Prof. Michael Bauer, MD Jena University, Jena, Germany
  • Dr. Cornelius (Neil) Clancy, University of Pittsburgh Medical Center, Pittsburgh, United States
  • Dr. Giulia De Angelis, Institute of Microbiology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy
  • Dr. Thomas Walsh, New York Presbyterian Hospital, New York City, United States